Effects of intracerebroventricular administration of the NPY-Y1 receptor antagonist, 1229U91, on hyperphagic and glycemic responses to acute and chronic intermediate insulin-induced hypoglycemia in female rats

Regulatory Peptides

Volumn 159, Issue 1-3, 2010, Pages 14-18

  Nedungadi, T Prashant ^a   Briski, Karen P ^a  

^a UNIVERSITY OF LOUISIANA AT MONROE   (United States)

Author keywords

Estradiol benzoate; Food intake; Neuropeptide Y; Neutral protamine Hagedorn insulin; Ovariectomy; Y1 receptor

Indexed keywords

GR 231118; ISOPHANE INSULIN; NEUROPEPTIDE Y1 RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; FOOD INTAKE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HYPERPHAGIA; HYPOGLYCEMIA; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; RECEPTOR BLOCKING;

ANIMALS; BLOOD GLUCOSE; FEEDING BEHAVIOR; FEMALE; HYPERPHAGIA; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; PEPTIDES, CYCLIC; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NEUROPEPTIDE Y; TIME FACTORS;

ANIMALIA; RATTUS;

EID: 71349084984     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2009.07.006     Document Type: Article

References (35)

1. Stanley B.G., and Leibowitz S.F. Neuropeptide Y injected in the paraventricular hypothalamus: a powerful stimulant of feeding behavior. Proc Natl Acad Sci 82 (1985) 3940-3943
2. Stanley B.G., Magdalin W., Seirafi A., Nguyen M.M., and Leibowitz S.F. Evidence for neuropeptide Y mediation of eating produced by food deprivation and for a variant of the Y1 receptor mediating this peptide's effect. Peptides 13 (1992) 581-587
3. Danger J.M., Tonon M.C., Jenks B.G., Saint-Pierre S., Martel J.C., Fasolo A., Breton B., Quirion R., Pelletier G., and Vaudry H. Neuropeptide Y: localization in the central nervous system and neuroendocrine functions. Fundam Clin Pharmacol 4 (1990) 307-340
4. Everitt B.J., Hökfelt T., Terenius L., Tatemoto K., Mutt V., and Goldstein M. Differential co-existence of neuropeptide Y (NPY)-like immunoreactivity with catecholamines in the central nervous system of the rat. Neuroscience 11 (1984) 443-462
5. Katatani A., Mashiko S., Murai N., Sugimoto N., Ito J., Fukuroda T., Futami T., Morin N., MacNeil D.J., Van der Ploeg L.H., Saga Y., Nishimura S., and Ihara M. Role of the Y1 receptor in the regulation of neuropeptide Y-mediated feeding: comparison of wild-type, Y1 receptor-deficient, and Y5 receptor-deficient mice. Endocrinology 141 (2000) 1011-1016
6. Henry M., Ghibaudi L., Gao J., and Hwa J.J. Energy metabolic profile of mice after chronic activation of central NPY Y1, Y2, and Y5 receptors. Obes Res 13 (2005) 36-47
7. Abbot C.R., Small C.J., Kennedy A.R., Neary N.M., Sajedi A., Ghatei M.A., and Bloom S.R. Blockade of the neuropeptide Y Y2 receptor with the specific antagonist BIIEO246 attenuates the effect of endogenous and exogenous peptide YY(3-26) on food intake. Brain Res 1043 (2005) 139-144
8. Sergeyev V., Broberger C., Gorbatyuk O., and Hökfelt T. Effect of 2-mercaptoacetate and 2-deoxy-D-glucose administration on the expression of NPY, AGRP, POMC, MCH and hypocretin/orexin in the rat hypothalamus. Neuroreport 11 (2000) 117-1121
9. Sindelar D.K., Ste Marie L., Miura G.I., Palmiter R.D., McMinn J.E., Morton G.J., and Schwartz M.W. Neuropeptide Y is required for hyperphagic feeding in response to neuroglucopenia. Endocrinology 145 (2004) 3363-3368
10. He B., White B.D., Edwards G.L., and Martin R.J. Neuropeptide Y antibody attenuates 2-deoxy-D-glucose induced feeding in rats. Brain Res 781 (1998) 348-350
11. Chang G.Q., Karatayev O., Davydova Z., Wortley K., and Leibowitz S.F. Glucose injection reduces neuropeptide Y and agouti-related protein expression in the arcuate nucleus: a possible physiological role in eating behavior. Brain Res Mol Brain Res 135 (2005) 69-80
12. Akabayashi A., Zaia C.T., Silva I., Chae H.J., and Leibowitz S.F. Neuropeptide Y in the arcuate nucleus is modulated by alterations in glucose utilization. Brain Res 621 (1993) 343-348
13. Dryden S., Pickavance L., Henderson L., and Williams G. Hyperphagia induced by hypoglycemia in rats is independent of leptin and hypothalamic neuropeptide Y (NPY). Peptides 19 (1998) 1549-1555
14. Corrin S.E., McCarthy H.D., McKibbin P.E., and Williams G. Unchanged hypothalamic neuropeptide Y concentrations in hyperphagic, hypoglycemic rats: evidence for specific metabolic regulation of hypothalamic NPY. Peptides 12 (1991) 425-430
15. Kalra S.P., Dube M.G., Sahu A., Phelps C.P., and Kalra P.S. Neuropeptide Y secretion increases in the paraventricular nucleus in association with increased appetite for food. Proc Natl Acad Sci 88 (1991) 10931-10935
16. Jhanwar-Uniyal M., Beck B., Burlet C., and Leibowitz S.F. Diurnal rhythm of neuropeptide Y-like immunoreactivity in the suprachiasmatic, arcuate and paraventricular nuclei and other hypothalamic sites. Brain Res 536 1-2 (Dec 17 1990) 331-334
17. Wilding I.P., Kruszynska Y.T., Lambert P.D., and Bloom S.R. Acute effects of central neuropeptide Y injection on glucose metabolism in fasted rats. Clin Sci 89 (1995) 543-548
18. Sainsbury A., Rohner-Jeanrenaud F., Grouzmann E., and Jeanrenaud B.A. Acute intracerebroventricular administration of neuropeptide Y stimulates corticosterone output and feeding but not insulin output in normal rats. Neuroendocrinology 63 (1996) 318-626
19. Parikh R., and Marks J.L. Metabolic and orexigenic effects of intracerebroventricular neuropeptide Y are attenuated by food deprivation. J Neuroendocrinol 9 (1997) 789-795
20. Nedungadi T.P., and Briski K.P. Effects of estradiol on acute and chronic insulin-induced hypoglycemia-associated patterns of arcuate neuropeptide Y, proopiomelanocortin, and cocaine- and amphetamine related-transcript gene expression in the ovariectomized female rat. Neuroendocrinology 86 (2007) 270-276
21. Briski KP, Parihar M. Effects of orchidectomy on adaptation of arcuate neuropeptide Y, proopiomelanocortin, and cocaine- and amphetamine related-transcript gene profiles to recurring insulin-induced hypoglycemia in the male rat. Neuropeptides 2008 under revision.
22. Schober D.A., Gackenheimer S.L., Heiman M.L., and Gehlert D.R. Pharmacological characterization of (125)I-1229U91 binding to Y1 and Y4 neuropeptide Y/Peptide YY receptors. J Pharmacol Exp Ther 293 (2000) 275-280
23. Kanatani A., Ishihara A., Asahi S., Tanaka T., Ozaki S., and Ihara M. Potent neuropeptide Y Y1 receptor antagonist, 1229U91: blockade of neuropeptide Y induced and physiological food intake. Endocrinology 137 (1996) 3177-3182
24. Kanatani A., Ito J., Ishihara A., Iwaasa H., Fukuroda T., Fukami T., MacNeil D.J., Van der Ploeg L.H., and Ihara M. NPY-induced feeding involves the action of a Y1-like receptor in rodents. Regul Pept 76 (1998) 409-415
25. DeBalbian-Verster F., Robinson C.A., Hengeveld C.A., and Bush E.S. Freedhand cerebroventricular injection technique for unanesthetized rats. Life Sci (1971) 1395-1402
26. Briski K.P., and Sylvester P.W. Acute inhibition of pituitary LH release in the male rat by the glucocorticoid agonist decadron phosphate. Neuroendocrinology 54 (1991) 313-320
27. Briski K.P., Marshall E.S., and Sylvester P.W. Effects of estradiol on glucoprivic transactivation of catecholaminergic neurons in the female rat caudal brainstem. Neuroendocrinology 73 (2001) 369-377
28. Parker E.M., Babij C.K., Balasubramaniam A., Burrier R.E., Guzzi M., Hamud F., Mukhopadhyay G., Rudinsky M.S., Tao Z., Tice M., Xia L., Mullins D.E., and Salisbury B.G. GR231118 (1229U91) and other analogues of the C-terminus of neuropeptide Y are potent neuropeptide Y Y1 antagonists and neuropeptide Y4 receptor agonists. Eur J Pharmacol 349 (1998) 97-105
29. Matthews J.E., Jansen M., Lyerly D., Cox R., Chen W.J., Koller K.J., and Daniels A.J. Pharmacological characterization and selectivity of the NPY antagonist GR231118 (1229U91) for different NPY receptors. Regul Pept 72 (1997) 113-119
30. Sylte I., Andrianjara C.R., Calvet A., Pascal Y., and Dahl S.G. Molecular dynamics of NPY Y1 receptor activation. Bioorg Med Chem 7 (1999) 2737-2748
31. Sjodin P., Holmsberg S.K., Akerberg H., Berglund M.M., Mohell N., and Larhammar D. Re-evaluation of receptor-ligand interactions of the human neuropeptide Y receptor Y1: a site-directed mutagenesis study. Biochem J 393 (2006) 161-169
32. Yokosuka M., Kalra P.S., and Kalra S.P. Inhibition of neuropeptide Y (NPY)-induced feeding and c-Fos response on magnocellular paraventricular nucleus by a NPY receptor antagonist: a site of NPY action. Endocrinology 140 (1999) 4494-4500
33. Sawchenko P.E., Swanson L.W., Grzanna R., Howe P.R., Bloom S.R., and Polak J.M. Colocalization of neuropeptide Y immunoreactivity in brainstem catecholaminergic neurons that project to the paraventricular nucleus of the hypothalamus. J Comp Neurol 241 (1985) 138-153
34. Sahu A, Kalra PS, Kalra SP. Food deprivation and ingestion induce reciprocal changes in neuropeptide Y concentrations in the paraventricular nucleus. Peptides 1988; 9: 83-86.
35. Beck B., Jhanwar-Uniyal M., Burlet A., Chapleur-Chateau M., Leibowitz S.F., and Burlet C. Rapid and localized alterations of neuropeptide Y in discrete hypothalamic nuclei with feeding status. Brain Res 528 (1990) 245-249